The CRISPR-Cas9 gene-editing tool makes it possible to modify the genetic material of organisms. But CRISPR technology is not perfect. Frequently, these molecular “scissors” also make incisions in genetic regions that have a similar appearance to the...More
We welcome applications from young European start-up companies looking to expand their profile, advance their business ideas and build relationships with life-science investors and supporters of innovation.
European life-science spin-offs and...More
Da die Bewerbung hierfür auf Englisch erfolgen muss, sind alle weiteren Informationen auf dieser Seite in Englischer Sprache verfasst.
ZNM – Zusammen Stark! e.V. – Research Grant Awards are designed to promote research in areas that...More
ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.
Founded in 2016, Lava Therapeutics works on the development of antibody...More
ADCC-enhancement for innovative cancer therapyMore
Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin are coordinating an international project on the single-cell analysis of the human pancreas. The project is part of a global undertaking – known as the...More
Ahead of the European Council negotiations on the next Multiannual Financial Framework,academic and industry leaders supporting the LifeTime initiative, have called members of the European Union into action. They ask to preserve the existing Horizon...More
European Advanced infraStructure for Innovative GenomicsMore
Accelerating new rare disease therapies through collaboration agreementMore